AP - A Los Angeles physician who investigators call the second most prolific provider of prescription drugs in the country has been convicted of 13 felony counts.

AP - Angiotech Pharmaceuticals Inc. said Monday a stent it developed with Boston Scientific Corp. met its goals in a pair of clinical trials.

AP - OSI Pharmaceuticals rejected a $3.5-billion takeover bid from Astellas Pharma Inc., telling shareholders Monday the offer was too low.

AP - Shares of Amylin Pharmaceuticals jumped 13 percent Monday as the Food and Drug Administration asked for more information on its potential diabetes treatment.

AP - BioSante Pharmaceuticals has received orphan drug status for its potential pancreatic cancer treatment, the company said Monday.

An experimental blood thinner developed by Merck and Portola Pharmaceuticals was found to be safe and effective in a mid-stage study presented Monday, with a lower incidence of serious bleeding than current drugs.

Prosecutors in California have said they are looking into a possible link between the death of Canadian actor Corey Haim and an illegal trade in prescription drugs.

AP - Endo Pharmaceuticals Holdings Inc. said Friday it hired former Nora Therapeutics CEO Julie McHugh as its new chief operating officer.

AP - Pharmacy benefits manager Medco Health Solutions Inc. said even though its CEO took a 7 percent pay cut in 2009, he still received $13.3 million in total compensation, according to Associated Press calculation of figures filed with regulators.

The insurance industry, the pharmaceutical industry, the American Medical Association, the hospital industry and the major business groups ferociously